Tenet Reports Results for the Third Quarter Ended September 30, 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Tesla acquires AI hardware company for up to $2 billion in stock
Tenet Healthcare (THC) PT Raised to $33 at Mizuho Securities
November 5, 2019 11:59 AM ESTMizuho Securities analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $33.00 (from $30.00) while maintaining a Buy rating.
The analyst commented, "We are raising our price target on THC to $33 (from $30) post a solid 3Q:19. Volume growth accelerated... More
Tenet Healthcare (THC) Tops Q3 EPS by 28c, Offers Q4 Guidance
November 4, 2019 4:21 PM ESTTenet Healthcare (NYSE: THC) reported Q3 EPS of $0.58, $0.28 better than the analyst estimate of $0.30. Revenue for the quarter came in at $4.57 billion versus the consensus estimate of $4.46 billion.
GUIDANCE:
Tenet Healthcare sees Q4 2019 EPS of $0.57-$1.23, versus the consensus of $1.00.... More
